Home » Newsletters » BioWorld Science

BioWorld Science

June 1, 2001

View Archived Issues

New porcine cell line producing porcine endogenous retrovirus available for licensing from NIH

Superior side effect profile of tolterodine vs. oxybutynin in overactive bladder

First mglu1 receptor antagonist with inverse agonist activity discovered at Bayer

Hemagen Diagnostics completes development of unique HIV diagnostic test

Synthetic fragment of secreted human peptide inhibits IL-8-induced nasal inflammation

Patient enrollment begins in SCLC trial of TAP-derived antibody-based therapy

Luveris reaches first market following late November approval by European Commission

Recent data for SDZ-ASM-981 summarized at scientific meeting and in medical journal

Novartis obtains license to Dr. Reddy's novel insulin sensitizer

Rigel boosts IgE receptor regulation program for asthma/allergy

Wilex antibody receives orphan drug status for RCC from FDA

Graffinity and Aventis sign drug discovery alliance

Amylin submits MAA for Symlin in the E.U.

BIIL-284: a potent, orally active LTB4 antagonist with promise in inflammatory diseases

Tripos and Lipha drug discovery alliance makes progress

Alzheimer's disease drug candidate shows promise in the laboratory

Significant survival benefit associated with rhAPC in PROWESS trial

MediGene completes patient enrollment in phase III trial of Polyphenon E

Company Profile: Paratek

Rofecoxib and celecoxib safe for use in aspirin-sensitive asthmatics

Company Profile: Neuronyx

New neuraminidase inhibitors in the Abbott pipeline

Natural plant extracts useful for psoriasis according to Scottish researchers

Antiproliferative agents with an indoline structure designed at Boehringer Ingelheim

Substituted pyrroles synthesized by Roche particularly useful in solid tumor therapy

P&G patents new series of matrix metalloproteinase inhibitors and their use

SGLT2 inhibitors useful alone and in combination for Rx of diabetes and related disorders

Antioxidant metalloporphyrins in development by UAB for neurological diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...